Coagulation and Fibrinolysis During the First Year of Immunosuppressive Treatment in Renal Transplantation: Correspondence Between Hypercoagulable State and Steroid Therapy
| Autor: | Antonio Girolami, Antonella Perin, Giovanni M. Patrassi, Paolo Rigotti, Panagiotis Theodoridis, Alessandra Casonato, Maria Teresa Sartori, Graziella Saggiorato, Domenico Di Landro |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty medicine.medical_treatment Disease 030204 cardiovascular system & hematology Tissue plasminogen activator Gastroenterology 03 medical and health sciences 0302 clinical medicine Internal medicine Fibrinolysis medicine Kidney transplantation medicine.diagnostic_test business.industry Incidence (epidemiology) Hematology General Medicine medicine.disease Surgery Transplantation 030104 developmental biology Coagulation business medicine.drug Partial thromboplastin time |
| Zdroj: | Clinical and Applied Thrombosis/Hemostasis. 1:277-282 |
| ISSN: | 1938-2723 1076-0296 |
| Popis: | An increased incidence of thromboembolic complications has been reported after kidney transplantation, and hypercoagulability has been associated with immunosuppressive treatment, specifically with Cyclosporin A. Hypercorticism due to prolonged steroid therapy or to Cushing's disease has been associated with a similar hypercoagulable state and thrombotic risk. The aims of this study were first to evaluate coagulation and fibrinolytic behavior in 27 patients at different times during the first year after renal transplantation and then to compare the same patients' coagulation and fibrinolytic findings 1 month after transplantation with those of a normal control group and a group of Cushing's patients. Compared with normal controls, renal transplant patients and Cushing's patients showed a similar hypercoagulable and hypofibrinolytic state, with a significant shortening in activated partial thromboplastin time and increase in factor VIII-von Willebrand factor complex, tissue plasminogen activator concentration, and plasminogen activator inhibitor activity and concentration. Other test results in the two groups showed no differences. The same abnormalities were present in the renal transplant group for the entire period of study. Our results suggest that a hypercoagulable and hypofibrinolytic state persists almost 1 year after renal transplantation and that these abnormalities are very similar to those present in Cushing's disease. Steroid treatment seems to play a key role in determining thromboembolic risk after renal transplantation. Key Words: Renal transplantation-Hypercoagulable state—von Willebrand factor-Hypofibrinolysis-Plasminogen activator inhibitor-Steroid therapy-Cyclosporin A. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|